SE436572B - Forfarande for framstellning av androstadien-17-karbonsyraestrar - Google Patents
Forfarande for framstellning av androstadien-17-karbonsyraestrarInfo
- Publication number
- SE436572B SE436572B SE7701999A SE7701999A SE436572B SE 436572 B SE436572 B SE 436572B SE 7701999 A SE7701999 A SE 7701999A SE 7701999 A SE7701999 A SE 7701999A SE 436572 B SE436572 B SE 436572B
- Authority
- SE
- Sweden
- Prior art keywords
- androstadien
- preparing
- procedure
- acid esters
- carbonic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH225376A CH628355A5 (de) | 1976-02-24 | 1976-02-24 | Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze. |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7701999L SE7701999L (sv) | 1977-08-25 |
SE436572B true SE436572B (sv) | 1985-01-07 |
Family
ID=4229445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7701999A SE436572B (sv) | 1976-02-24 | 1977-02-23 | Forfarande for framstellning av androstadien-17-karbonsyraestrar |
Country Status (26)
Country | Link |
---|---|
US (1) | US4285937A (es) |
JP (1) | JPS52102264A (es) |
AT (1) | AT361141B (es) |
AU (1) | AU513559B2 (es) |
BE (1) | BE851725A (es) |
CA (1) | CA1084483A (es) |
CH (4) | CH628355A5 (es) |
CY (1) | CY1198A (es) |
DD (1) | DD145918A5 (es) |
DE (1) | DE2707336A1 (es) |
DK (1) | DK153493C (es) |
ES (5) | ES456134A1 (es) |
FR (2) | FR2342302A1 (es) |
GB (1) | GB1578243A (es) |
HK (1) | HK57483A (es) |
HU (1) | HU176762B (es) |
IE (1) | IE45023B1 (es) |
IL (2) | IL51519A (es) |
KE (1) | KE3300A (es) |
MX (1) | MX9203366A (es) |
MY (1) | MY8500017A (es) |
NL (1) | NL7701886A (es) |
NZ (1) | NZ183418A (es) |
SE (1) | SE436572B (es) |
SG (1) | SG37383G (es) |
ZA (1) | ZA771087B (es) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0197018A1 (en) * | 1985-04-04 | 1986-10-08 | Aktiebolaget Draco | 16,17-Acetal-substituted androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them |
EP0200692A1 (en) * | 1985-04-04 | 1986-11-05 | Aktiebolaget Draco | Androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
PT69411A (en) * | 1978-04-05 | 1979-04-01 | Syntex Inc | 4-halo etianic acids and derivatives thereof |
US4198403A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes |
DE3024008C2 (de) * | 1980-06-24 | 1982-04-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 17α-Hydroxy-etiocarbonsäuren |
US4607028A (en) * | 1983-08-18 | 1986-08-19 | Ciba-Geigy Corporation | Novel carboxylic acid esters |
SE8306370D0 (sv) * | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
WO1990015816A1 (en) * | 1989-06-16 | 1990-12-27 | The Upjohn Company | Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
US5981517A (en) * | 1996-05-09 | 1999-11-09 | Soft Drugs, Inc. | Androstene derivatives |
GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
AR032471A1 (es) * | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6858593B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
CA2445839A1 (en) * | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
KR20060032596A (ko) * | 2003-06-19 | 2006-04-17 | 니콜라스 에스. 보도 | 국부 또는 다른 국소 투여를 위한 연성 항염증스테로이드의 활성 및/또는 작용기간의 증진 |
DE602004008083T2 (de) * | 2003-06-19 | 2008-04-24 | Nicholas S. Gainsville Bodor | Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
AU2006305620A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US7687484B2 (en) * | 2006-05-25 | 2010-03-30 | Bodor Nicholas S | Transporter enhanced corticosteroid activity |
US7691811B2 (en) * | 2006-05-25 | 2010-04-06 | Bodor Nicholas S | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
US8227027B2 (en) | 2007-12-07 | 2012-07-24 | Presspart Gmbh & Co. Kg | Method for applying a polymer coating to an internal surface of a container |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US8835410B2 (en) | 2011-05-10 | 2014-09-16 | Bodor Laboratories, Inc. | Treatment of eyelid dermatitis |
CN111100176A (zh) * | 2019-12-20 | 2020-05-05 | 重庆华邦胜凯制药有限公司 | 一种化合物的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636010A (en) * | 1968-12-23 | 1972-01-18 | Ciba Geigy Corp | Esters of steroid-17-carboxylic acids |
GB1384372A (en) * | 1971-01-20 | 1975-02-19 | Glaxo Lab Ltd | Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids |
GB1438940A (en) * | 1972-07-19 | 1976-06-09 | Glaxo Lab Ltd | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids |
GB1514476A (en) * | 1974-08-30 | 1978-06-14 | Glaxo Lab Ltd | Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates |
US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
-
1976
- 1976-02-24 CH CH225376A patent/CH628355A5/de not_active IP Right Cessation
-
1977
- 1977-02-18 CY CY1198A patent/CY1198A/xx unknown
- 1977-02-18 GB GB6955/77A patent/GB1578243A/en not_active Expired
- 1977-02-19 DE DE19772707336 patent/DE2707336A1/de active Granted
- 1977-02-22 FR FR7705053A patent/FR2342302A1/fr active Granted
- 1977-02-22 NL NL7701886A patent/NL7701886A/xx unknown
- 1977-02-22 CA CA272,291A patent/CA1084483A/en not_active Expired
- 1977-02-22 DD DD77197502A patent/DD145918A5/de unknown
- 1977-02-22 IL IL51519A patent/IL51519A/xx unknown
- 1977-02-22 ES ES456134A patent/ES456134A1/es not_active Expired
- 1977-02-23 IE IE382/77A patent/IE45023B1/en not_active IP Right Cessation
- 1977-02-23 HU HU77CI1720A patent/HU176762B/hu unknown
- 1977-02-23 BE BE175169A patent/BE851725A/xx not_active IP Right Cessation
- 1977-02-23 NZ NZ183418A patent/NZ183418A/xx unknown
- 1977-02-23 DK DK079077A patent/DK153493C/da not_active IP Right Cessation
- 1977-02-23 ZA ZA00771087A patent/ZA771087B/xx unknown
- 1977-02-23 AT AT119477A patent/AT361141B/de not_active IP Right Cessation
- 1977-02-23 AU AU22572/77A patent/AU513559B2/en not_active Expired
- 1977-02-23 SE SE7701999A patent/SE436572B/xx not_active IP Right Cessation
- 1977-02-24 JP JP1874377A patent/JPS52102264A/ja active Granted
-
1978
- 1978-01-27 FR FR7802324A patent/FR2369297A1/fr active Granted
- 1978-03-01 ES ES467430A patent/ES467430A1/es not_active Expired
- 1978-03-01 ES ES467432A patent/ES467432A1/es not_active Expired
- 1978-03-01 ES ES467433A patent/ES467433A1/es not_active Expired
- 1978-03-01 ES ES467434A patent/ES467434A1/es not_active Expired
-
1979
- 1979-10-30 US US06/089,677 patent/US4285937A/en not_active Expired - Lifetime
-
1980
- 1980-11-19 IL IL61512A patent/IL61512A0/xx unknown
-
1981
- 1981-06-11 CH CH383381A patent/CH628641A5/de not_active IP Right Cessation
- 1981-06-11 CH CH383181A patent/CH629824A5/de not_active IP Right Cessation
- 1981-06-11 CH CH383281A patent/CH628356A5/de not_active IP Right Cessation
-
1983
- 1983-06-23 KE KE3300A patent/KE3300A/xx unknown
- 1983-06-27 SG SG373/83A patent/SG37383G/en unknown
- 1983-11-17 HK HK574/83A patent/HK57483A/xx unknown
-
1985
- 1985-12-30 MY MY17/85A patent/MY8500017A/xx unknown
-
1992
- 1992-06-25 MX MX9203366A patent/MX9203366A/es unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0197018A1 (en) * | 1985-04-04 | 1986-10-08 | Aktiebolaget Draco | 16,17-Acetal-substituted androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them |
EP0200692A1 (en) * | 1985-04-04 | 1986-11-05 | Aktiebolaget Draco | Androstane-17-beta-carboxylic-acid esters, process for their preparation and pharmaceutical compound containing them |
EP0355859A1 (en) * | 1985-04-04 | 1990-02-28 | Aktiebolaget Draco | Process for the preparation of intermediates for 11-beta,16-alpha,17-alpha,21-tetrahydroxypregna-3,20-dione 16-alpha,17-alpha-acetals and 21-esters thereof |
US4950659A (en) * | 1985-04-04 | 1990-08-21 | Aktiebolaget Draco | 16,17-acetalsubstituted androstane-17β-carboxylic acid esters prossessing high binding affinity to the glucocorticosteroid receptor |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE436572B (sv) | Forfarande for framstellning av androstadien-17-karbonsyraestrar | |
SE442295B (sv) | Forfarande for framstellning av 4-amino-5-en-hexansyra | |
TR19755A (tr) | Tereftalik asidin hazirlanmasina mahsus usul | |
SE440501B (sv) | Forfarande for framstellning av substituerade fenylamidoximer | |
SE441360B (sv) | Forfarande for framstellning av fosfonsyraderivat | |
NO773548L (no) | Fremgangsmaate for fremstilling av spiro-hydantoinderivater | |
NO771578L (no) | Fremgangsmaate for fremstilling av di-n-propyleddiksyre | |
GB1523530A (en) | Tetrazole - 5-carboxylic acid esters | |
SE7803853L (sv) | Forfarande for framstellning av estrar av oxalsyra | |
SE7802609L (sv) | Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat | |
SE431871B (sv) | Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin | |
SE421125B (sv) | Forfarande for framstellning av 5-m-tolyloxiuracil | |
SE7709071A0 (sv) | Olivansyraestrar | |
NO821484L (no) | Fremgangsmaate for fremstilling av fosfonsyrederivater | |
SE421787B (sv) | Forfarande for framstellning av kvadratsyra | |
NO773622L (no) | Fremgangsmaate til fremstilling av tereftalsyre | |
SE418287B (sv) | Forfarande for framstellning av guajakol-p-isobutyl-hydratropat | |
SE434157B (sv) | Forfarande for framstellning av 6-aminopenicillansyra | |
NO145234C (no) | Fremgangsmaate for fremstilling av alfa-cyano-benzyl-karboksylat-estere. | |
NO141716C (no) | Fremgangsmaate for fremstilling av tiokarbaminsyreestere | |
SE7609954L (sv) | Furanos-o-pyridylkarboxylsyraestrar | |
SE434743B (sv) | Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider | |
NO142121C (no) | Fremgangsmaate til fremstilling av perpropionsyreopploesoninger | |
DK390277A (da) | Fremgangsmaade til fremstilling af thiocarbaminsyreestere | |
SE435291B (sv) | Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7701999-0 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7701999-0 Format of ref document f/p: F |